Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Orthofix Medical
OFIX
$388M
| $362K | ﹤0.01% |
11,305
-59,324
| -84% | -$1.97M |
|
3527
Amgen
AMGN
$240B
| $360K | ﹤0.01% |
1,528
-14,564
| -91% | -$3.32M |
|
3528
Accuray
ARAY
$32.9M
| $360K | ﹤0.01% |
+177,097
| New | +$369K |
|
3529
Spok Holdings
SPOK
$220M
| $360K | ﹤0.01% |
+38,492
| New | +$399K |
|
|
IDEX
3530
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $360K | ﹤0.01% |
1,434
-1,807
| -56% | -$209K |
|
|
AGTC
3531
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $360K | ﹤0.01% |
65,000
| – | – |
|
3532
RB Global
RBA
$15.5B
| $359K | ﹤0.01% |
+8,793
| New | +$360K |
|
3533
Triumph Financial Inc
TFIN
$1.75B
| $359K | ﹤0.01% |
14,807
-1,793
| -11% | -$44K |
|
3534
Silicon Laboratories
SLAB
$7.27B
| $358K | ﹤0.01% |
3,572
-86,514
| -96% | -$8.09M |
|
3535
Gogo Inc
GOGO
$355M
| $356K | ﹤0.01% |
+112,771
| New | +$242K |
|
|
AXDX
3536
DELISTED
Accelerate Diagnostics
AXDX
| $355K | ﹤0.01% |
2,345
-242
| -9% | -$23.9K |
|
3537
BCE
BCE
$22B
| $355K | ﹤0.01% |
8,491
-37,992
| -82% | -$1.56M |
|
3538
Invesco
IVZ
$14.5B
| $355K | ﹤0.01% |
32,979
-1,047,724
| -97% | -$9.4M |
|
|
GSS
3539
DELISTED
Golden Star Resources Ltd.
GSS
| $355K | ﹤0.01% |
+122,477
| New | +$318K |
|
|
ENZ
3540
DELISTED
Enzo Biochem, Inc.
ENZ
| $354K | ﹤0.01% |
157,855
+29,935
| +23% | +$77K |
|
|
RIVE
3541
DELISTED
Riverview Financial Corporation Common Stock
RIVE
| $354K | ﹤0.01% |
65,849
+1,717
| +3% | +$10.2K |
|
|
CIIC
3542
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $354K | ﹤0.01% |
35,756
-14,244
| -28% | -$139K |
|
3543
Bank7 Corp
BSVN
$497M
| $353K | ﹤0.01% |
32,538
-37,049
| -53% | -$342K |
|
3544
Invesco Senior Loan ETF
BKLN
$6.78B
| $351K | ﹤0.01% |
+16,420
| New | +$347K |
|
3545
United Microelectronic
UMC
$49.5B
| $351K | ﹤0.01% |
132,945
+92,728
| +231% | +$233K |
|
3546
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
| $349K | ﹤0.01% |
+9,853
| New | +$334K |
|
3547
Alpha Pro Tech
APT
$53.7M
| $348K | ﹤0.01% |
19,653
+4,581
| +30% | +$63.3K |
|
3548
BlackBerry
BB
$4.6B
| $345K | ﹤0.01% |
70,496
-430,874
| -86% | -$1.95M |
|
3549
Everspin Technologies
MRAM
$440M
| $344K | ﹤0.01% |
48,976
+22,389
| +84% | +$110K |
|
|
OPOF
3550
DELISTED
Old Point Financial
OPOF
| $344K | ﹤0.01% |
22,576
-1,263
| -5% | -$19.7K |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.